Literature DB >> 19943329

Statistical design for a small serial dilution series.

Daniel Zelterman1, Alexander Tulupyev, Robert Heimer, Nadia Abdala.   

Abstract

We describe statistical plans for a serial dilution series designed to detect and estimate the number of viral particles in a solution. The design addresses a problem when a very limited number of aliquots are available for proliferation. A gamma prior distribution on the number of viral particles allows us to describe the marginal probability distribution of all experimental outcomes. We examine a design that minimizes the expected reciprocal information and compare this with the maximum entropy design. We argue that the maximum entropy design is more useful from the point of view of the laboratory technician. The problem and design are motivated by our study of the viability of human immunodeficiency virus in syringes and other equipment that might mediate blood-borne viral transmission. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 19943329      PMCID: PMC3113538          DOI: 10.1002/sim.3774

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

1.  Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users.

Authors:  N Abdala; A A Gleghorn; J M Carney; R Heimer
Journal:  J Acquir Immune Defic Syndr       Date:  2001-12-15       Impact factor: 3.731

2.  Statistical inference for serial dilution assay data.

Authors:  M L Lee; G A Whitmore
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

3.  Bias-corrected confidence intervals for the concentration parameter in a dilution assay.

Authors:  J Wang; S Basu
Journal:  Biometrics       Date:  1999-03       Impact factor: 2.571

4.  Bayesian analysis of serial dilution assays.

Authors:  Andrew Gelman; Ginger L Chew; Michael Shnaidman
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

5.  A mixed model for repeated dilution assays.

Authors:  J Bloch; M Chavance
Journal:  Biometrics       Date:  1998-06       Impact factor: 2.571

6.  Alternative criteria for optimal designs of limiting dilution assays.

Authors:  J N Matthews
Journal:  Stat Med       Date:  1998-12-15       Impact factor: 2.373

7.  Survival of HIV-1 in syringes.

Authors:  N Abdala; P C Stephens; B P Griffith; R Heimer
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-01-01

8.  The effect of serial dilution error on calibration inference in immunoassay.

Authors:  K M Higgins; M Davidian; G Chew; H Burge
Journal:  Biometrics       Date:  1998-03       Impact factor: 2.571

9.  Dilution assay statistics.

Authors:  L E Myers; L J McQuay; F B Hollinger
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

10.  Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories.

Authors:  F B Hollinger; J W Bremer; L E Myers; J W Gold; L McQuay
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

  10 in total
  1 in total

1.  A two-stage experimental design for dilution assays.

Authors:  Jake M Ferguson; Tanya A Miura; Craig R Miller
Journal:  Biometrics       Date:  2019-04-03       Impact factor: 2.571

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.